Journal article
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6
Abstract
Early-stage Hodgkin lymphoma has become one of the most curable hematologic malignancies. Depending upon the disease location, possible toxicities, and patient preference, chemotherapy alone with ABVD remains an accepted treatment modality for this disease. There remains a paucity of data regarding the longitudinal trajectory of health-related quality of life (HRQoL) in patients treated for HL. The impact of disease and treatment on HRQoL is …
Authors
Mian H; Ringash J; Meyer R; Hay AE; Shepherd L; Djurfeldt M; Winter JN; Sussman J; Pater J; Chen BE
Journal
Supportive Care in Cancer, Vol. 31, No. 5,
Publisher
Springer Nature
Publication Date
May 2023
DOI
10.1007/s00520-023-07717-3
ISSN
0941-4355